脂肪生成
脂肪性肝炎
基因敲除
脂肪变性
脂肪肝
非酒精性脂肪肝
PI3K/AKT/mTOR通路
癌症研究
内科学
小发夹RNA
甾醇调节元件结合蛋白
蛋白激酶B
生物
内分泌学
脂质代谢
化学
细胞生物学
医学
信号转导
基因表达
生物化学
疾病
基因
作者
Ming Zhang,Xiaoming Chi,Na Qu,Congying Wang
标识
DOI:10.1016/j.bbrc.2018.03.127
摘要
Non-alcoholic fatty liver disease and steatohepatitis (NAFLD and NASH) account for the majority of liver disease in industrialized countries. However, the pathogenesis still unclear. Long non-coding RNAs (lncRNAs) has been reported to be involved in various pathophysiological processes. Here, we reported a novel role of lncARSR in hepatic lipogenesis in NAFLD. The expression of lncARSR was induced both in NAFLD patients and mouse model, as well as in hepatocytes treated with fatty acid. Moreover, overexpression of lncARSR enhanced while knockdown of lncARSR ameliorated hepatic lipid accumulation in vivo and in vitro. Furthermore, the expression of genes related to fatty acid synthesis and oxidation increased with lncARSR overexpression in vivo. Mechanistically, we identified that lncARSR regulated hepatic lipogenesis via upregulating SREBP-1c, the key regulatory molecule involved in lipogenesis. Knockdown of SREBP-1c by shRNA blocked the effect of lncARSR on lipogenesis. Furthermore, we demonstrated that lncARSR regulated SREBP-1c expression by PI3K/Akt pathway. In conclusion, our data indicated that lncARSR potentially contributes to the hepatic steatosis in NAFLD, which may be a new therapeutic target against NAFLD.
科研通智能强力驱动
Strongly Powered by AbleSci AI